BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34372259)

  • 1. Multiplexed Prostate Cancer Companion Diagnostic Devices.
    Aidoo-Brown J; Moschou D; Estrela P
    Sensors (Basel); 2021 Jul; 21(15):. PubMed ID: 34372259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical prostate-specific antigen biosensors based on electroconductive nanomaterials and polymers.
    Dowlatshahi S; Abdekhodaie MJ
    Clin Chim Acta; 2021 May; 516():111-135. PubMed ID: 33545110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed Opto-Microfluidic Biosensing: Advanced Platform for Prostate Cancer Detection.
    Funari R; Chu KY; Shen AQ
    ACS Sens; 2024 May; 9(5):2596-2604. PubMed ID: 38683677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology.
    Liu N; Liang W; Ma X; Li X; Ning B; Cheng C; Ou G; Wang B; Zhang J; Gao Z
    Biosens Bioelectron; 2013 Sep; 47():92-8. PubMed ID: 23567627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated biomarker sensors: advancements in prostate cancer diagnosis.
    Abd Rahman SF; Md Arshad MK; Gopinath SCB; Fathil MFM; Sarry F; Ibau C
    Chem Commun (Camb); 2021 Sep; 57(76):9640-9655. PubMed ID: 34473143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Enhanced Optical Biosensing Technologies for Prostate Specific Antigen Biomarker Detection.
    Usman A
    IEEE Rev Biomed Eng; 2022; 15():122-137. PubMed ID: 33136544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portable and Rapid Dual-Biomarker Detection Using Solution-Gated Graphene Field Transistors in the Accurate Diagnosis of Prostate Cancer.
    Deng M; Yang H; Zhang H; Li C; Chen J; Tang W; Wang X; Chen Z; Li J
    Adv Healthc Mater; 2024 Jan; 13(3):e2302117. PubMed ID: 37922499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensors for prostate cancer detection.
    Akbari Nakhjavani S; Tokyay BK; Soylemez C; Sarabi MR; Yetisen AK; Tasoglu S
    Trends Biotechnol; 2023 Oct; 41(10):1248-1267. PubMed ID: 37147246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer.
    Liang H; Wang X; Li F; Xie Y; Shen J; Wang X; Huang Y; Lin S; Chen J; Zhang L; Jiang B; Xing J; Zhu J
    Biosens Bioelectron; 2023 Sep; 235():115380. PubMed ID: 37207584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors.
    Singh S; Gill AAS; Nlooto M; Karpoormath R
    Biosens Bioelectron; 2019 Jul; 137():213-221. PubMed ID: 31100601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care Prostate Specific Antigen Testing: Examining Translational Progress toward Clinical Implementation.
    Garg S; Sachdeva A; Peeters M; McClements J
    ACS Sens; 2023 Oct; 8(10):3643-3658. PubMed ID: 37830899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biomarkers biosensor with just-in-time functionalization: Application to prostate cancer detection.
    Parra-Cabrera C; Samitier J; Homs-Corbera A
    Biosens Bioelectron; 2016 Mar; 77():1192-200. PubMed ID: 26590517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated lab-on-a-chip-based electrochemical biosensor for rapid and sensitive detection of cancer biomarkers.
    Uludag Y; Narter F; Sağlam E; Köktürk G; Gök MY; Akgün M; Barut S; Budak S
    Anal Bioanal Chem; 2016 Nov; 408(27):7775-7783. PubMed ID: 27562751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparticles.
    Pan LH; Kuo SH; Lin TY; Lin CW; Fang PY; Yang HW
    Biosens Bioelectron; 2017 Mar; 89(Pt 1):598-605. PubMed ID: 26868935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdigitated impedimetric-based Maackia amurensis lectin biosensor for prostate cancer biomarker.
    Rahman SFA; Arshad MKM; Gopinath SCB; Fathil MFM; Sarry F; Ibau C; Elmazria O; Hage-Ali S
    Mikrochim Acta; 2024 Jan; 191(2):118. PubMed ID: 38296851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
    Li J; Veltri RW; Yuan Z; Christudass CS; Mandecki W
    PLoS One; 2015; 10(4):e0122249. PubMed ID: 25853582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
    Hendriks RJ; van Oort IM; Schalken JA
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.